ALZERTA DOS POR SEMANA 4,6 MG/24 H PARCHES TRANSDERMICOS

Esteve Pharmaceuticals S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 4c93e6d690e56261
Drug Cima Aemps Name: ALZERTA DOS POR SEMANA 4,6 MG/24 H PARCHES TRANSDERMICOS
Register Number: 86148
Holder Company Name: Esteve Pharmaceuticals S.A.
Marketing Company Name: Esteve Pharmaceuticals S.A.
Holder Company Detail Path: /organization/esteve-pharmaceuticals-s-a
Marketing Company Detail Path: /organization/esteve-pharmaceuticals-s-a
Authorization Date: 2021-08-10
Dosage Form: PARCHE TRANSDÉRMICO
Dose: 4.6 mg/24 h
Route Of Administration: VÍA TRANSDÉRMICA
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Esteve Pharmaceuticals S.A.
Company Detail Path: /organization/esteve-pharmaceuticals-s-a

RIVASTIGMINA

25,92 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 10, 2021

Approval ID

4c93e6d690e56261

Type

Standard